Tumor-immune system interaction: Modeling the tumor-stimulated proliferation of effectors and immunotherapy

Mathematical Models and Methods in Applied Sciences

Volumn 16, Issue 8, 2006, Pages 1375-1401

  D'Onofrio, A ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Immune system; Interacting populations; Limit cycles; Therapies; Tumor

Indexed keywords

EID: 33747088162     PISSN: 02182025     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218202506001571     Document Type: Review

References (50)

1. Ed. S. A. Agarwala, New applications of cancer immunotherapy, Sem. Oncology, Special Issue 29-3 Suppl. 7 (2003).
2. B. Alberts et al., Molecular Biology of the Cell (Garland, 2005).
3. I. Bell, Predators-preys equation simulating immune response, Math. Biosci. 16 (1973) 291-314.
4. N. Bellomo and L. Preziosi, Modelling and mathematical problems related to tumor evolution and its interaction with the immune system, Math. Comp. Model. 32 (2000) 413-452.
5. N. Bellomo, A. Bellouquid and M. Delitala, Mathematical topics on the modelling complex multicellular systems and tumor immune cells competition, Math. Mod. Meth. Appl. Sci. 14 (2004) 1683-1733.
6. N. Bellomo and P. K. Maini, Introduction to Special Issue on Cancer Modelling, Math. Mod. Meth. Appl. Sci. 15 (2005) iii.
7. A. Bellouquid and M. Delitala, Mathematical methods and tools of kinetic theory towards modelling complex biological systems, Math. Mod. Meth. Appl. Sci. 15 (2005) 1639-1667.
8. I. Bleumer, E. Oosterwijk, P. de Mulder and P. F. Mulders, Immunotherapy for renal cell carcinoma, Eur. Urology 44 (2003) 65-75.
9. P. Boyle et al., European code against cancer and scientific justification, Ann. Oncology 14 (2003) 973-1005.
10. P. Boyle, A. d'Onofrio, P. Maisonneuve, G. Severi, C. Robertson, M. Tubiana and U. Veronesi, Measuring progress against cancer in Europe: Has the 15% decline targeted for 2000 come about?, Ann. Oncology 14 (2003) 1312-1325.
11. F. M. Burnet, Cancer - A biological approach, Brit. Med. J. 1 (1957) 841-847.
12. J. B. Collings, The effects of functional response on the bifurcation behavior of a mite predator-prey interaction model, J. Math. Biol. 36 (1997) 149-168.
13. V. T. de Vito, Jr., J. Hellman and S. A. Rosenberg, Cancer: Principles and Practice of Oncology (J. P. Lippincott, 2005).
14. L. G. de Pillis, A. E. Radunskaya and C. L. Wiseman, A validated mathematical model of cell-mediated immune response to tumor growth, Cancer Res. 65 (2005) 7950-7958.
15. H. P. de Vladar and J. A. Gonzalez, Dynamic response of cancer under the influence of immunological activity and therapy, J. Th. Biol. 227 (2004) 335-348.
16. D. Xiao and Z. F. Zhang, On the uniqueness of limit cycles for predator-prey systems, Nonlinearity 16 (2003) 1185-1201.
17. A. d'Onofrio and A. Gandolfi, Tumour eradication by antiangiogenic therapy: Analysis and extensions of the model by Hahnfeldt et al. (1999), Math. Biosci. 191 (2004) 159-184.
18. A. d'Onofrio, A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences, Phys. D 208 (2005) 220-235.
19. A. d'Onofrio, Tumor evasion form immune system control: strategies of a MISS to become a MASS, Chaos Solitons and Fractal (2006) (in press).
20. A. d'Onofrio, Cellular growth: Linking the mechanistic to the phenomenological modeling and vice versa by extending the approach by Mombach et al., submitted (2005).
21. G. P. Dunn, L. J. Old and R. D. Schreiber, The three ES of cancer immunoediting, Ann. Rev. Immun. 22 (2004) 329-360.
22. P. Ehrlich, Ueber den jetzigen Stand der Karzinomforschung, Ned. Tijdschr. Geneeskd. 5 (1909) 273-290.
23. A. Friedman and G. Lolas, Analysis of a mathematical model of tumor lymphangiogenesis, Math. Mod. Meth. Appl. Sci. 15 (2005) 95-107.
24. M. Galach, Dynamics of the tumor-immune system competition: The effect of time delay, Int. J. Appl. Math Comp. Sci. 13 (2003) 395-406.
25. R. A. Gatenby, T. L. Vincent and R. J. Gillies, Evolutionary dynamics in carcinogenesis, Math. Mod. Meth. Appl. Sci. 15 (2005) 1619-1639.
26. J. M. Kaminski, J. B. Summers, M. B. Ward, M. R. Huber and B. Minev, Immunotherapy and prostate cancer, Canc. Treat. Rev. 29 (2004) 199-209.
27. B. J. Kennedy, Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy, Blood 35 (1970) 751-760.
28. D. Kirschner and J. C. Panetta, Modeling immunotherapy of the tumor -Immune interaction, J. Math. Biol. 37 (1998) 235-252.
29. V. A. Kuznetsov, I. A. Makalkin, M. A. Taylor and A. S. Perelson, Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis, Bull. Math. Biol. 56 (1994) 295-321.
30. V. A. Kuznetsov and G. D. Knott, Modeling tumor regrowth and immunotherapy, Math. Comp. Mod. 33 (2001) 1275-1287.
31. M. C. Mackey, http://www.cnd.mcgill.ca/bios/mackey/mackey.html.
32. M. C. Mackey, Periodic auto-immune hemolytic anemia: An induced dynamical disease, Bull. Math. Biol. 41 (1979) 829-834.
33. M. Marusic, Z. Bajzer, J. P. Freyer and S. Vuk-Pavlovic, Analysis of growth of multicellular tumour spheroids by mathematical models, Cell Prolif. 27 (1994) 73-94.
34. C. J. M. Melief, Cancer Immunology: Cat and mouse games, Nature 437 (2005) 41-42.
35. J. D. Murray, Mathematical Biology (Springer-Verlag, 2003).
36. D. Pardoll, Does the immune system see tumors as foreign or self?, Ann. Rev. Immun. 21 (2003) 807-839.
37. M. Pekham, H. M. Pinedo and U. Veronesi, Oxford Textbook of Oncology (Oxford Medical Publications, 1995).
38. M. J. Quinn, A. d'Onofrio, B. Moeller, R. Black, C. Martinez-Garcia, H. Moeller, M. Rahu, C. Robertson, L. J. Schouten, C. La Vecchia, and P. Boyle, Cancer mortality trends in the EU and acceding countries up to 2015, Ann. Oncology 14 (2003) 1148-1152.
39. S. Ruan and D. M. Xiao, Global analysis in a predator-prey system with nonmonotonic functional response, SIAM J. Appl. Anal. 61 (2001) 1445-1472.
40. R. V. Sole, Phase transitions in unstable cancer cell populations, Eur. J. Phys. B 35 (2003) 117-124.
41. N. V. Stepanova, Course of the immune reaction during the development of a malignant tumor, Biophys. 24 (1980) 917-923.
42. S. Szymanska, Analysis of the immunotherapy models in the context of cancer dynamics, Int. J. Appl. Math Comp. Sci. 13 (2003) 407-418.
43. H. Tsao, A. B. Cosimi and A. J. Sober, Ultra-late recurrence (15 years or longer) of cutaneous melanoma, Cancer 79 (1997) 2361-2370.
44. T.-W. Hwang, Uniqueness of the limit cycle for gause-type predator-prey systems, J. Math. Anal. Appl. 238 (1999) 179-185.
45. A. P. Vicari, G. Caux and G. Trinchieri, Tumour escape from immune surveillance through dendritic cell inactivation, Sem. Canc. Biol. 12 (2002) 33-42.
46. T. L. Vincent and J. S. Brown, Evolutionary Game Theory, Natural Selection and Darwinian Dynamics (Cambridge Univ. Press, 2005).
47. H. Vodopick, E. M. Rupp, C. L. Edwards, F. A. Goswitz and J. J. Beauchamp, Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia, New Engl. J. Med. 286 (1972) 284-290.
48. T. E. Wheldon, Mathematical Models in Cancer Research (Hilger, 1988).
49. T. L. Whiteside, Tumor-induced death of immune cells: Its mechanisms and consequences, Sem. Canc. Biol. 12 (2002) 43-50.
50. P. Zhivkov and J. Waniewski, Modelling tumor-immunity interaction with different stimulation functions, Int. J. Appl. Math Comp. Sci. 13 (2003) 307-315.